Regulatory Affairs Services Provider in Georgia
Georgia has evolved into a pivotal destination for pharmaceutical expansion, acting as a strategic corridor between European and CIS markets. This unique geographical and political position offers significant opportunities for international manufacturers, yet the market remains characterized by a regulatory environment in flux. As Georgia continues to align its legislative framework with European Union standards and international benchmarks, successful market entry requires more than just technical compliance; it demands a partner with deep local intelligence to navigate the nuances of administrative expectations and evolving quality standards.
Drug Regulatory Framework in Georgia
The primary oversight of the pharmaceutical sector in Georgia is managed by the State Regulation Agency for Medical Activities (formerly LEPL). Operating under the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs, this agency is responsible for the entire spectrum of pharmaceutical regulation, including the registration of medicinal products, licensing of facilities, and enforcement of quality standards.
The agency’s approach is heavily influenced by the World Health Organization (WHO) and the International Council for Harmonisation (ICH). Georgia is recognized for its pragmatic "Recognition" system, which streamlines access for products already approved in highly regulated jurisdictions. However, the agency maintains a rigorous "National Procedure" for new chemical entities or products originating from non-recognized markets, ensuring that public health is protected through stringent safety and efficacy evaluations.
Registration Pathways and Dossier Requirements
Manufacturers entering the Georgian market must choose between two primary registration routes, depending on the product’s global authorization status.
-
The Recognition Procedure
For products already authorized by stringent regulatory authorities—such as the EMA, US FDA, or agencies in Japan, Canada, and Australia—Georgia offers an expedited Recognition route. This procedure focuses on administrative verification and labeling compliance, significantly shortening the time to market. -
The National Registration Procedure
The National Procedure applies to products that do not qualify for recognition. This involves a comprehensive scientific assessment of the product’s quality, safety, and efficacy data.
Georgia accepts the Common Technical Document (CTD) format, allowing for the reuse of core scientific data (Modules 2–5). However, Module 1 is subject to specific localization requirements:
- Local Representation: A local applicant or legal representative is a mandatory requirement to serve as the official liaison with the State Regulation Agency for Medical Activities.
- Language and Labeling: While scientific modules are often accepted in English, the Summary of Product Characteristics (SmPC), Patient Information Leaflet (PIL), and all secondary packaging must be meticulously translated into the Georgian language.
- GMP Certification: Since early 2026, the enforcement of Good Manufacturing Practice (GMP) has become stricter. All new registrations must be accompanied by GMP certification for both the finished product and the active pharmaceutical ingredients (API).
Key Regulations Overview in Georgia
Strategic planning for Regulatory Affairs Services in Georgia must be grounded in the following legal pillars:
- Law of Georgia on Medicines and Pharmaceutical Activities: The primary legislative act governing the manufacture, import, and distribution of medicines.
- Decree No. 11/N: Detailed rules regarding the registration procedure and specific requirements for the Recognition route.
- Order on GMP Standards: Defines the mandatory quality production standards, aligning Georgian domestic manufacturing with global excellence.
Our Regulatory Affairs Services Expertise in Georgia
- End-to-end product registration and marketing authorization in Georgia
- In-country representation and authorized local representative services
- Strategic regulatory affairs consulting and submission planning
- Dossier gap analysis and compliance alignment with Georgian guidelines
- Query management and communication support with the Regulation Agency
- Pharmaceutical product lifecycle compliance and maintenance
- Expert regulatory consultation and guidance
- Regulatory support for labeling, variations, and renewals
- Monitoring of Georgian regulatory updates and legislative amendments
Why choose DDReg for Regulatory Affairs Services in Georgia?
What sets DDReg apart as a Pharma regulatory consultant in Georgia is our ability to balance global standards with local administrative nuance. We don't just process paperwork; we provide a strategic layer of intelligence that anticipates regulatory trends before they become bottlenecks.
Our expertise in the Caucasus region allows us to manage complex submissions with a high first time-right ratio. By leveraging our established workflows and technical depth in CMC (Chemistry, Manufacturing, and Controls), we minimize the risk of "Clock Stops" and administrative delays. We understand that Georgia is often a key piece in a larger regional puzzle, and our team ensures your compliance in Tbilisi supports your broader international objectives.
Position your products for success in a growing market. Let DDReg manage the complexities of Georgian pharmaceutical law while you focus on innovation.
Global Reach Explorer
Find Your Solution
Our Regulatory Affairs Consulting Services in Georgia portfolio covers:
Regulatory Strategies
The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...
New Product Marketing Authorizations
Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...
Gap Analysis and Remediation
In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...
Regulatory Due Diligence
Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...
API & DMF services
Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...
CMC Advisory
DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...
Post Approval Life Cycle Management
Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...
Certification Services
Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...
ANDA and MA Holder Services
Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.
Publishing & Submission
Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...
